Google Alert - pharmaceutical news

News 8 new results for pharmaceutical news

Stellar Pharmaceuticals Reports First Quarter 2012 Financial Results MarketWatch (press release) MILTON, ONTARIO, May 15, 2012 (MARKETWIRE via COMTEX) -- Stellar Pharmaceuticals Inc. (otcqb:SLXCF) (OTN:SLXCF) (pinksheets:SLXCF) ("Stellar" or "the Company"), an emerging specialty pharmaceutical company with a primary focus on the acquisition, ... See all stories on this topic »

Sunesis Pharmaceuticals Reports First Quarter 2012 Financial Results and ... MarketWatch (press release) SOUTH SAN FRANCISCO, Calif., May 15, 2012 (GlobeNewswire via COMTEX) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today reported financial results for the quarter ended March 31, 2012. Net loss for the three months ended March 31, 2012 was $13.9 ... See all stories on this topic »

US panel gives nod to new obesity drug Hindustan Times A panel of experts on Thursday urged US regulators to approve what could be the first new anti-obesity drug on the market in more than a decade -- Lorcaserin, made by Arena Pharmaceuticals. in the brain, after trial data showed it helped nearly half of ... See all stories on this topic » Hindustan Times

Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and ... MarketWatch (press release) This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey. See all stories on this topic »

Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical ... MarketWatch (press release) EWING, NJ, May 15, 2012 (BUSINESS WIRE) -- Antares Pharma, Inc. (ASE:AIS) today announced the appointment of LeRoux Jooste to the position of Senior Vice President of Pharmaceutical Sales and Marketing. Mr. Jooste has more than 25 years of experience ... See all stories on this topic »

ProMetic Receives $4.2 Million Follow-on Order from Major Global ... MarketWatch (press release) ... Inc. (TOR:CA:PLI) ("ProMetic"or the "Corporation") announced today that it has received a $4.2 million follow-on purchase order pursuant to its ongoing long-term supply agreement entered into with a major global pharmaceutical company in 2009. See all stories on this topic »

Furiex Pharmaceuticals and Menarini Announce License Agreement for Priligy® Genetic Engineering News (press release) Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy® in Europe, most of Asia, Africa, Latin America and ... See all stories on this topic »

Cardinal facility suspended under DEA settlement Reuters India Cardinal spokeswoman Debbie Mitchell said the agreement provided "certainty and resolution" and would enable the company, one of the largest US wholesalers of pharmaceuticals, to avoid a protracted dispute with federal officials. See all stories on this topic »

---

Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.